This site uses cookies.

Judicial College Guidelines 16th Edition: Damages for Asbestos-Related Disease - Jim Hester, Parklane Plowden Chambers

02/12/22. This is my last article on the new (16th Edition) of the Judicial College guidelines, following earlier articles on Work-related Limb Disorders and Noise Induced Hearing Loss. This article covers Asbestos-Related Disease.

 What stays the same?

The answer is short – most of it. There is some, but not substantial, change to this part of the JC Guidelines.

Asbestos-Related Disease remains within Sub-Section (C) to Chapter 6 – Injuries to Internal Organs.

What is different?

As is common with the Guidelines in general there is an increase of about 6.56% to take into account inflation. See below for more about the effects of inflation, however.

As is also common with other parts of the guidelines – pre-Simmons v Castle figures have been removed. There is one exception to this within this guideline, however.

The mesothelioma figures are pre-Simmons v Castle being reflective of the typical funding arrangements. Accordingly if there is not a pre-LASPO CFA in place, then the figures for PSLA for mesothelioma need to be increased by 10%.

There is some re-wording of sub-section (d) in relation to Asbestosis and pleural thickening. This is the section regarding disability up to 10% which is clarified to mean the current level of disability. To reflect the rewording, the upper level has in fact lowered (from £36,060 to £35,500), as has the lower level of bracket (c) – for respiratory disability in excess of 10%.


There are no enormous changes to this part of the guidelines, though the basis of the mesothelioma PSLA figure is worth noting.

Likewise the clarification of bracket for respiratory disability of about 10% is useful (now said to be £32,500 – £35,500 for about a 10% disability itself).

Interestingly, the increase in RPI since the September 2021 figures (which the Guidelines reference) and the time of writing (figures for August 2022) is from 308.6 to 345.2. This is a little over 11.1% – greater than the increase for inflation between the 15th and 16th versions of the Guidelines themselves.

This article was originally published at

Image ©

All information on this site was believed to be correct by the relevant authors at the time of writing. All content is for information purposes only and is not intended as legal advice. No liability is accepted by either the publisher or the author(s) for any errors or omissions (whether negligent or not) that it may contain. 

The opinions expressed in the articles are the authors' own, not those of Law Brief Publishing Ltd, and are not necessarily commensurate with general legal or medico-legal expert consensus of opinion and/or literature. Any medical content is not exhaustive but at a level for the non-medical reader to understand. 

Professional advice should always be obtained before applying any information to particular circumstances.

Excerpts from judgments and statutes are Crown copyright. Any Crown Copyright material is reproduced with the permission of the Controller of OPSI and the Queen’s Printer for Scotland under the Open Government Licence.